Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM

    2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .

    [doi:10.1111/pcmr.12472]

  • Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X

    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood 127 1907-1911. .

    [doi:10.1182/blood-2015-09-669036]

  • Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M

    Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice

    ENDOCRINE-RELATED CANCER 23 7-11. .

    [doi:10.1530/ERC-15-0585]

  • Papathomas TG; Pucci E; Giordano TJ; Lu H; Duregon E; Volante M; Papotti M; Lloyd RV; Tischler AS; van Nederveen FH; Nose V; Erickson L; Mete O; Asa SL; Turchini J; Gill AJ; Matias-Guiu X; Skordilis K; Stephenson TJ; Tissier F; Feelders RA; Smid M; Nigg A; Korpershoek E; van der Spek PJ; Dinjens WN; Stubbs AP; de Krijger RR

    An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 40 569-576. .

    [doi:10.1097/PAS.0000000000000574]

  • Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M

    Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .

    [doi:10.1016/j.bbadis.2016.01.018]

  • Buj, R; Mallona, I; Diez-Villanueva, A; Barrera, V; Mauricio, D; Puig-Domingo, M; Reverter, JL; Matias-Guiu, X; Azuara, D; Ramirez, JL; Alonso, S; Rosell, R; Capella, G; Perucho, M; Robledo, M; Peinado, MA; Jorda, M

    Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples

    Oncotarget 7 10536-10546. .

    [doi:10.18632/oncotarget.7233]

  • Del Carmen S; Gatius S; Franch-Arcas G; Baena JA; Gonzalez O; Zafon C; Cuevas D; Valls J; Pérez A; Martinez M; Ros S; Macías CG; Iglesias C; Matías-Guiu X; de Álava E

    Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid

    HUMAN PATHOLOGY 48 132-141. .

    [doi:10.1016/j.humpath.2015.09.020]

  • Colombo, N.; Creutzberg, C.; Amant, F.; Bosse, T.; González-Martón, A.; Ledermann, J.; Marth, C.; Nout, R.; Querleu, D.; Mirza, M.R.; Sessa, C.; Abal, M.; Altundag, O.; Amant, F.; Banerjee, S.; Bosse, T.; Casado, A.; De Agustín, L.C.; Cibula, D.; Colombo, N.; Creutzberg, C.; Del Campo, J.-M.; Emons, G.; Goffin, F.; González-Martín, A.; Greggi, S.; Haie-Meder, C.; Katsaros, D.; Kesic, V.; Kurzeder, C.; Lax, S.; Lécuru, F.; Ledermann, J.; Levy, T.; Lorusso, D.; Mäenpää, J.; Marth, C.; Matias-Guiu, X.; Morice, P.; Nijman, H.W.; Nout, R.; Powell, M.; Querleu, D.; Mirza, M.R.; Reed, N.; Rodolakis, A.; Salvesen, H.; Sehouli, J.; Sessa, C.; Taylor, A.; Westermann, A.; Zeimet, A.G.

    ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

    ANNALS OF ONCOLOGY 27 16-41. .

    [doi:10.1093/annonc/mdv484]

  • Gatius, S; Matias-Guiu, X

    Practical issues in the diagnosis of serous carcinoma of the endometrium

    Modern Pathology 29 45-58. .

    [doi:10.1038/modpathol.2015.141]

  • Cantelli G; Orgaz JL; Rodriguez-Hernandez I; Karagiannis P; Maiques O; Matias-Guiu X; Nestle FO; Marti RM; Karagiannis SN; Sanz-Moreno V

    TGF-beta-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination

    CURRENT BIOLOGY 25 2899-2914. .

    [doi:10.1016/j.cub.2015.09.054]

  • Romero-Pérez L; Garcia-Sanz P; Mota A; Leskelä S; Hergueta-Redondo M; Díaz-Martín J; López-García MA; Castilla MA; Martínez-Ramírez A; Soslow RA; Matias-Guiu X; Moreno-Bueno G; Palacios J

    A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern Pathology 28 1492-1503. .

    [doi:10.1038/modpathol.2015.102]

  • Gracia A; Balañá C; Kaskens L; Chiavenna S; Matias-Guiu X; Rubio-Rodríguez D; Rubio-Terrés C; Iglesias L; Esteller M

    ECONOMIC ANALYSIS OF EPICUP, AN EPIGENETIC TEST TO PREDICT THE TISSUE OF ORIGIN IN CANCER OF UNKNOWN PRIMARY SITE, THE USA PAYORS PERSPECTIVE

    VALUE IN HEALTH 18 356-356. .

    [doi:10.1016/j.jval.2015.09.670]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU